Literature DB >> 3500060

Recognition by major histocompatibility complex class I-restricted cytolytic T lymphocytes of cells expressing vaccinia-encoded viral and class I proteins.

M E Andrew1, B E Coupar, D B Boyle, R V Blanden.   

Abstract

Target cells expressing influenza virus hemagglutinin (HA) could be recognized by cytotoxic T lymphocytes (CTL) in conjunction with the murine major histocompatibility complex class I antigen, H-2Kd, when both antigens were encoded by recombinant vaccinia virus. This recognition occurred if HA and H-2Kd were encoded by separate vaccinia viruses following dual infection of target cells or if HA and H-2Kd were encoded by a single recombinant virus. In contrast, target cells expressing nucleoprotein (NP) were only recognized by H-2Kd-restricted CTL if both NP and H-2Kd were encoded by the same vaccinia virus. These results show that the requirements for association of H-2Kd with different viral antigens derived from HA or NP can vary. Possible factors contributing to this difference are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500060     DOI: 10.1002/eji.1830171021

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.

Authors:  M K Spriggs; B H Koller; T Sato; P J Morrissey; W C Fanslow; O Smithies; R F Voice; M B Widmer; C R Maliszewski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.

Authors:  M Lobigs; A Müllbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

Authors:  M E Boursnell; E Rutherford; J K Hickling; E A Rollinson; A J Munro; N Rolley; C S McLean; L K Borysiewicz; K Vousden; S C Inglis
Journal:  Vaccine       Date:  1996-11       Impact factor: 3.641

4.  Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein.

Authors:  J Skipper; H J Stauss
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.